Previous Close | 1.1700 |
Open | 1.1900 |
Bid | 1.1100 x 1000 |
Ask | 1.1400 x 1000 |
Day's Range | 1.1200 - 1.2300 |
52 Week Range | 0.3330 - 19.4700 |
Volume | |
Avg. Volume | 1,992,698 |
Market Cap | 112.406M |
Beta (5Y Monthly) | 0.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vertex (VRTX) signs a collaboration agreement with TreeFrog to utilize the latter's C-Stem technology in order to optimize the production of its T1D cell therapies.
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.